In a partnership between Empire State Development, Upstate Medical University, the SUNY Research Foundation, and Excell Partners, the newly-launched Upstate Biotech Ventures invests in high-potential startups and small businesses affiliated with Upstate Medical University to drive research and technology innovation.
Over the last 5 years we have seen unprecedented growth in research at Upstate. For the last 3 years our research expenditures rose 10% annually and we finished the 2023/24 fiscal year with a 23% increase in research expenditures. Over the last ten years we have nearly doubled our expenditures, closing out 2023/24 at $55 million.
Behind all this, everything research is growing at Upstate; our faculty and students are publishing more papers, submitting more and bigger grants, new clinical trials are being established at record rates, we are setting records for new intellectual property disclosures, patents filed, and patents awarded and we are best in the SUNY system for IP revenue. Through our Innovate Upstate initiative we are breaking down the walls to make ourselves a preferred partner for industry and industry collaboration and as a result are seeing a large expansion in industry engagement. To keep up with all this growth we have expanded our world class support team in Research Administration and continue to invest in new instrumentation in our many state-of-the-art research cores. As our reputation as a world class biomedical research enterprise grows, we have become a destination of choice for top biomedical researchers in the country as we expand our research faculty.
- Dave Amberg, PhD